Open-label, Single Arm, Multicenter, Phase IIIStudy on the Efficacy, Safety, and Pharmacokinetics of FP-001 42 mg ControlledRelease in Patients with Central (Gonadotropin-Dependent) Precocious Puberty

Project: Research project

Project Details

Description

Open-label, Single Arm, Multicenter, Phase III Study on the Efficacy, Safety, and Pharmacokinetics of FP-001 42 mg Controlled Release in Patients with Central (Gonadotropin-Dependent) Precocious Puberty
StatusActive
Effective start/end date10/18/22 → 11/30/27

Funding

  • FORESEE PHARMACEUTICALS USA, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint